IL18 and Insulin resistance: Lindegaard et al. identified in mice experiments that IL-18 can activate the adenosine monophosphate activated protein kinase (AMPK) signaling pathway, which enhances fat oxidation in skeletal muscles and sequentially reduces insulin resistance induced by HFD [81].